Cyclosporine A-induced gingival hyperplasia pemphigus vulgaris: Literature review and report of a case

Journal of Periodontology

Volumn 71, Issue 4, 2000, Pages 650-656

  Oettinger Barak, Orit ^a   Machtei, Eli E ^a,b   Peled, Micha ^a,b   Barak, Shlomi ^a   L Naaj, Imad Abu ^b   Laufer, Dov ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cyclosporine adverse effects; Gingival hyperplasia etiology; Pemphigus vulgaris; Planing; Scaling; Tooth root

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; GINGIVA HYPERPLASIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; PATHOPHYSIOLOGY; PEMPHIGUS VULGARIS; PERIODONTICS;

EID: 0033858631     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2000.71.4.650     Document Type: Article

References (57)

1. Gilman AG. Drugs used for immunomodulation. In: Hardman JG, Limbird LE, Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 9th ed. New York: Pergamon Press; 1995:1296-1300.
2. Britton S, Palacios R. Cyclosporin A - usefulness, risks and mechanism of action. Immunol Rev 1982;65:5-22.
3. Hess AD, Colombani PN. Cyclosporin-resistant and sensitive T-lymphocyte subsets. Ann Inst Pasteur Immunol 1987;138:606-611.
4. Seymour RA, Jacob DJ. Cyclosporin and the gingival tissues. J Clin Periodontol 1992;19:1-11.
5. Beveridge T, Grawtwohl A, Michot F. Cyclosporin A: pharmacokinetics after a single dose in man and serum levels after multiple dosing in recipient of allogenic bone marrow grafts. Curr Ther Res 1981;30:5-18.
6. Maurer G. Metabolism of Cyclosporin. Transpl Proc 1985;17:19-25.
7. Kronbach T, Fischer V, Meyer (JA. Cyclosporine metabolism in human liver: identification of a cytochrome P-450 III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988;43:630-635.
8. Rateitchak-Pluss EM, Hefti A, Lortscher R, Thiel G. Initial observations that Cyclosporin A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
9. Starzl TE, Weil R, Iwatsuki S, et al. The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet 1980;151:17-26.
10. Calne RY, Rolles K, White DJG, et al. Cyclosporin A in clinical organ grafting. Transpl Proc 1981;13:349-358.
11. Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. J Clin Periodontol 1987;14:610-613.
12. Daley TD, Wysocki GP, May C. Clinical and pharmacological correlations in cyclosporin-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986; 62:417-421.
13. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: A side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
14. Somacarrera ML, Hernandez G, Acero J, Moscow BS. Factors related to the incidence and severity of cyclosporine-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994; 65:671-675.
15. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991;18:107-110.
16. Sooriyamoorthy M, Gower DB, Eley BM. Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporin. J Periodont Res 1990;25:25-30.
17. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.
18. Tyldeseley WR, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984;157:305-309.
19. Friskopp J, Klintmalm G. Gingival enlargement. A comparison between cyclosporine and azathioprine treated renal allograft recipients. Swed Dent J 1986; 10:85-92.
20. Deliliers GL, Santoro F, Polli N, Bruno E, Fumagalli L, Risciotti E. Light and electron microscopic study of cyclosporin A-induced gingival hyperplasia. J Periodontol 1986;57:771-775.
21. Friskopp J, Engstrom PE, Sundqvist KG. Characterization of mononuclear cells in cyclosporin A induced gingival enlargement. Scand J Dent Res 1986;94:443-447.
22. Rostock MH, Fry HR, Turner JE. Severe gingival over-growth associated with cyclosporine therapy. J Periodontol 1986;57:294-299.
23. Pisanti S, Shoshan S, Chajek T, Maftsir G, Sacks B, Benezra D. The effect of cyclosporin A (CsA) treatment on gingival tissue of patients with Behcet's disease. J Periodontol 1988;59:599-603.
24. Coley C, Jarvis K, Hassell T. Effect of cyclosporine A on human gingival fibroblasts in vitro. J Dent Res 1986;65(Spec. Issue):353(Abstr. 1658).
25. Zebrowski EJ, Singer DL, Brunka JR. CyclosporinA, nifedipine and phenytoin: comparative effects on gingival fibroblast metabolism. J Dent Res 1986; 65(Spec. Issue):331(Abstr. 1456).
26. Sobhani S, Hassell TM, Stone C. Patient age and susceptibility to gingival enlargement: in vitro study. J Dent Res 1989;68(Spec. Issue):416(Abstr. 1873).
27. Tipton DA, Dabbous MK. Heterogeneity of gingival fibroblast response to cyclosporine. J Dent Res 1986; 65(Spec. Issue):331(Abstr. 1457).
28. Yamasaki A, Rose GG, Pinero GJ, Mahan CJ. ultra-structure of fibroblasts in cyclosporin A-induced gingival hyperplasia. J Oral Pathol 1987;16:129-134.
29. Mariani G, Calastrini C, Carinci F, Marzola R, Calura G. ultrastructural features of cyclosporine A-induced gingival hyperplasia. J Periodontol 1993;64:1092-1097.
30. Postlethwaite AE, Lachman LB, Mainardi CL, Kang AH. Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J Exp Med 1983;157:801-806.
31. Jacobs D, Buchanan J, Cuchens M, Hassell TM. The effect of cyclosporin metabolite OL-17 on gingival fibroblast subpopulations. J Dent Res 1990;69(Spec. Issue):221(Abstr. 899).
32. Seibel W, Yahia N, Stone C, Hassell T. Elevated protein synthesis of cultured fibroblasts after cyclosporin-A therapy in beagles. J Dent Res 1989;67(Spec. Issue):288(Abstr. 853).
33. Tipton DA, Stricklin GP, Dabbous MK. Fibroblast heterogeneity in collagenolytic response to cyclosporine. J Cell Biochem 1991;46:152-165.
34. Gonzalez FJ. Human cytochromes P450: problems and prospects [review]. Trends Pharmacol Sci 1992;13:346-352.
35. Thomason JM, Seymour RA, Ellis JS, et al. Determinants of gingival overgrowth severity in organ transplant patients. An examination of the role of HLA phenotype. J Clin Periodontol 1996;23:628-634.
36. Pernu EH, Knuuttila MLE, Huttenen KRH, Tiilikainen ASK. Drug-induced gingival overgrowth and class II major histocompatibility antigens. Transplantation 1994;57:1811-1813.
37. King GN, Fullinfaw R, Higgins TS, Walker RJ, Francis DMA, Wiesenfeld D. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonist. J Clin Periodontol 1993;20:286-293.
38. McGaw T, Lam S, Coates J. Cyclosporin-induced gingival overgrowth: correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64:293-297.
39. Adams D, Davies G. Gingival hyperplasia associated with cyclosporin A: a report of 2 cases. Br Dent J 1984;157:89-90.
40. Modeer T, Wondimu B, Larsson E, Jonzon B. Levels of cyclosporin-A (CsA) in saliva in children after oral administration of the drug in mixture or in capsule form. Scand J Dent Res 1992;100:366-370.
41. Regezi JA, Sciubba J. Oral Pathology: Clinical-Pathologic Correlations. Philadelphia: WB Saunders Co.; 1993:25-27.
42. Langlais RP, Miller CS. Color Atlas of Common Oral Diseases. Philadelphia: Lea & Febiger; 1992:92-93.
43. Fine JD. Management of acquired bullous skin disease. N Engl J Med 1995;333:1475-1484.
44. Lapidoth M, David M, Den-Amitai D, Katzenelson V, Lustig S, Sandbank M. The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study. J Am Acad Dermatol 1994;30:752-757.
45. Brown RS, Beaver WT, Bottomeley WK. On the mechanism of drug induced gingival hyperplasia. J Oral Pathol Med 1991;20:201-209.
46. Piattelli A, Petrelli I, Fanci P. Regression following reduction of the daily drug dosage in cyclosporin-A-induced gingival overgrowth in bone marrow transplant recipients. Acta Stomatol Belgica 1993;90:171-176.
47. Williams R, Neuhaus P, Bismuth H, et al. Two-year data from the European multicentre tacrolimus (FK506) liver study. Transpl Int 1996;9(Suppl. 1):S144-S150.
48. Bader G, Lejeune S, Messner M. Reduction of cyclosporine-induced gingival overgrowth following a change to tacrolimus. A case history involving a liver transplant patient. J Periodontol 1998;69:729-732.
49. Kantarci A, Cebeci I, Tuncer O, Carin M, Firatli E. Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia. J Periodontol 1999;70:587-593.
50. Rossman JA, Ingles E, Brown RS. Multimodal treatment of drug-induced gingival hyperplasia in a kidney transplant patient. Compendium Cont Educ Dent 1994; 15:1266-1276.
51. Pilloni A, Camargo PM, Crere M, Carranza FA. Surgical treatment of cyclosporine A- and nifedipine-induced gingival enlargement: gingivectomy versus periodontal flap. J Periodontol 1998;69:791-797.
52. Pernu HE, Hannele Pernu LM, Knuuttila MLE. Effect of periodontal treatment on gingival overgrowth among cyclosporine A-treated renal transplant recipients. J Periodontol 1993;64:1098-1100.
53. Saravia ME, Svirsky JA, Friedman R. Chlorhexidine as an oral hygiene adjunct for cyclosporine-induced gingival hyperplasia. J Dent Child 1990;57:366-370.
54. Ciancio SG, Bartz NW, Lauciello FR. Cyclosporine-induced gingival hyperplasia and chlorhexidine: A case report, Int J Periodontics Restorative Dent 1991;11:241-245.
55. Flotra L, Gjermo P, Rolla G, Waerhaug J. Side effects of chlorhexidine mouthwashes. Scand J Dent Res 1971; 79:119-125.
56. Wahlstrom E, Zamora JU, Teichman S. Improvement in cyclosporine-associated gingival hyperplasia with azithromycin therapy. N Engl J Med 1995;332:753.
57. Gomez E, Sanchez-Nunez M, Sanchez JE, et al. Treatment of cyclosporin-induced gingival hyperplasia with azithromycin. Nephrol Dial Transplant 1997;12:2684-2697.